Glycerol and bacterial meningitis.
Sáez-Llorens
Xavier
X
Department of Infectious Diseases, University of Panama School of Medicine, Hospital del Niño, Panama City, Panama.
McCracken
George H
GH
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant / Q000379:methods*; D002648:Child; D002675:Child, Preschool; D003907:Dexamethasone / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005990:Glycerol / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D016920:Meningitis, Bacterial / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D008583:Meningitis, Haemophilus / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D008585:Meningitis, Meningococcal / Q000188:drug therapy / Q000382:microbiology; D009422:Nervous System Diseases / Q000517:prevention & control*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D003907:Dexamethasone; D005990:Glycerol